Noi abordări în cancerul colorectal

Author:

Grigorescu Alexandru

Abstract

Colon cancer is one of the most common localizations of cancer in our time. In this short presentation, I will present some aspects of the systemic therapy of advanced colon cancer. Not being able to have an exhaustive approach, I consider that emphasizing the importance of ctDNA determination in the therapeutic indication and the involvement of precision medicine in the treatment of this cancer are of first importance. Also, colon cancer is found especially at advanced ages, and I considered it necessary to emphasize the role of geriatric consultation in these patients. This review also presents a practical aspect in chemotherapy for the elderly, namely the stability of the indication for cytostatic oxaliplatin treatment which in certain patients does not bring any benefit.

Publisher

MedicHub Media

Reference14 articles.

1. Innocenti F, Mu W, Qu X, et al. DNA Mutational Profiling in Patients with Colorectal Cancer Treated with Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations. J Clin Oncol. 2024;42(4):399-409.

2. Findings from an exploratory preplanned biomarker analysis of the PARADIGM study. 16 February 2024. https://www.esmo.org/oncology-news/a-lack-of-resistance-gene-alterations-in-baseline-ctdna-associated-with-prolonged-os-after-first-line-treatment-with-panitumumab-plus-chemotherapy-in-patients-with-ras-wt-mcrc?utm_source=SciNews&utm_medium=email&utm_campaign=ESMO-WW-MED-Members-Scientific-enews-email-SciNews-20240222

3. Shitara K, Muro K, Jun Watanabe J, et al. Negative hyperselection of patients with RAS wild-type metastatic colorectal cancer for panitumumab: A biomarker study of the phase III PARADIGM trial. Journal of Clinical Oncology. 2023;41(Suppl_4).

4. Oxaliplatin in Older Adults With Resected Colorectal Cancer?. https://www.medscape.com/viewarticle/999630?form=fpf

5. Quasar Collaborative Group, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370(9604):2020-2029 .

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3